Cargando…

Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is the prototype of autoimmune diseases, characterized by extensive gene expression perturbations in peripheral blood immune cells. Circumstantial evidence suggests that these perturbations may be due to altered epigenetic profiles and chromatin accessibility but t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ntasis, Vasilis F., Panousis, Nikolaos I., Tektonidou, Maria G., Dermitzakis, Emmanouil T., Boumpas, Dimitrios T., Bertsias, George K., Nikolaou, Christoforos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539002/ https://www.ncbi.nlm.nih.gov/pubmed/33024230 http://dx.doi.org/10.1038/s41598-020-73654-4

Ejemplares similares

Extensive Changes in Transcription Dynamics Reflected on Alternative Splicing Events in Systemic Lupus Erythematosus Patients
por: Papanikolaou, Sofia, et al.
Publicado: (2021)

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
por: Banos, Aggelos, et al.
Publicado: (2023)

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
por: Panousis, Nikolaos I, et al.
Publicado: (2019)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
por: Nikolopoulos, Dionysis, et al.
Publicado: (2019)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023)

Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
por: Nakou, Magdalene, et al.
Publicado: (2010)

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus
por: Grigoriou, Maria, et al.
Publicado: (2020)

Correction: Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
por: Nakou, Magdalene, et al.
Publicado: (2013)

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Changing paradigms in the treatment of systemic lupus erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
por: Emmanouilidou, Evgenia, et al.
Publicado: (2023)

Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis
por: Frangou, Eleni, et al.
Publicado: (2022)

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2020)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
por: Nikolopoulos, Dionysis, et al.
Publicado: (2022)

Allelic mapping bias in RNA-sequencing is not a major confounder in eQTL studies
por: Panousis, Nikolaos I, et al.
Publicado: (2014)

Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies
por: Adamichou, Christina, et al.
Publicado: (2017)

Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005)

Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner
por: Gergianaki, Irini, et al.
Publicado: (2018)

Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2018)

Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors
por: Arnaud, Laurent, et al.
Publicado: (2020)

Extensive Hypertrophic Lupus Erythematosus: Atypical Presentation
por: Narang, Tarun, et al.
Publicado: (2012)

REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)
por: Frangou, Eleni, et al.
Publicado: (2019)

Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
por: Alunno, Alessia, et al.
Publicado: (2019)

A complete tool set for molecular QTL discovery and analysis
por: Delaneau, Olivier, et al.
Publicado: (2017)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood
por: Papanikolaou, Sofia, et al.
Publicado: (2022)

Investigating the Role of T-bet(+) B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
por: Sachinidis, Athanasios, et al.
Publicado: (2023)

Extensive aortic aneurysm associated with neonatal lupus erythematosus
por: Akbariasbagh, Parvin, et al.
Publicado: (2016)

Extensive oral ulcer in a patient with lupus erythematosus
por: Patrocínio, Victor Hugo, et al.
Publicado: (2019)

A Very Extensively Diffused Case of Lupus Erythematosus
por: Jamieson, W. Allan
Publicado: (1878)

Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
por: Ruiz-Irastorza, Guillermo, et al.
Publicado: (2020)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
por: Kostopoulou, Myrto, et al.
Publicado: (2020)

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Andreoli, L, et al.
Publicado: (2017)

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus
por: Penha, Mariana Álvares, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_de1or8sfek8o1vtv6va0f0jtdr